Average Co-Inventor Count = 4.29
ph-index = 20
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (55 from 666 patents)
2. Global Blood Therapeutics, Inc. (22 from 57 patents)
3. Incyte Holdings Corporation (17 from 147 patents)
4. Kosan Biosciences Incorporated (8 from 110 patents)
5. Cytokinetics, Inc. (3 from 257 patents)
6. University of California (2 from 15,515 patents)
7. Pfizer Corporation (1 from 4,455 patents)
8. Incyte Corportion (1 from 1 patent)
87 patents:
1. 12084449 - Imidazotriazines and imidazopyrimidines as kinase inhibitors
2. 11530191 - Compounds and uses thereof for the modulation of hemoglobin
3. 11401280 - Pyrimidinones as PI3K inhibitors
4. 11286243 - Ferroportin inhibitors and methods of use
5. 11261191 - Imidazotriaines and imidazopyrimidines as kinase inhibitors
6. 11236109 - Compounds and uses thereof for the modulation of hemoglobin
7. 11014884 - Modulators of hemoglobin
8. 10829470 - Compounds and uses thereof for the modulation of hemoglobin
9. 10829502 - Pyrimidinones as PI3K inhibitors
10. 10822326 - Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
11. 10806733 - Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
12. 10738052 - Imidazotriaines and imidazopyrimidines as kinase inhibitors
13. 10435393 - Compounds and uses thereof for the modulation of hemoglobin
14. 10428087 - Pyrimidinones as PI3K inhibitors
15. 10377741 - Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation